Zobrazeno 1 - 10
of 42
pro vyhledávání: '"C. Cusa"'
Publikováno v:
Oxidative Medicine and Cellular Longevity, Vol 2019 (2019)
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity
The present study discusses about the effects of a combination of probiotics able to stimulate the immune system of patients affected by Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME). To this purpose, patients diagnosed according to Fuk
Autor:
Michele Ghitti, Letizia Venturini, Giovanni Ricevuti, Enrica Capelli, C. Cusa, Lorenzo Lorusso
Publikováno v:
International journal of immunopathology and pharmacology. 28(1)
In this study we analyzed the clinical features of a population of Italian patients with chronic fatigue syndrome (CFS) diagnosed according to the CDC-1994 criteria. The aim was to investigate CFS patients and their relatives, in order to search for
Publikováno v:
Current Therapeutic Research. 60:357-362
This paper describes 2 patients with pyoderma gangrenosum (PG) as a complication of ulcerative colitis; both cases were treated successfully with a prostaglandin I 2 (PGI 2 ) analogue (Iloprost) administered by intravenous infusion. The cutaneous les
Autor:
D. Gritti, Iolanda Mazzucchelli, I Buggia, C. Cusa, Gianluca Fossati, Luigi Bucci, Stefano Ghio, Monia Vezzoli, Antonino Mazzone, M. B Regazzi
Publikováno v:
European Journal of Clinical Investigation. 29:1-5
Background Endothelial vascular tone modulators are thought to be involved in aetiopathogenesis of systemic sclerosis (SS) and of peripheral artery occlusive disease (PAOD). Iloprost, a prostacyclin (PGI2) analogue, induces clinical benefit in patien
Autor:
Antonino Mazzone, C. Cusa
Publikováno v:
Drugs of today (Barcelona, Spain : 1998). 38(10)
Atherosclerotic lesions result from a series of highly specific cellular and molecular responses to various endogenous risk factors and potential exogenous antigens. The cellular mechanisms involved in atherogenesis, with the exception of calcificati
Publikováno v:
European journal of clinical investigation. 32(12)
Iloprost has beneficial effects on microcirculation by preventing platelet and leukocyte reciprocal activation, which is known to lead to endothelial damage and acute thrombosis. This drug also reduces inflammatory system activation by decreasing alp
Autor:
Monia Vezzoli, Elena Ottini, Piergiorgio Zuccaro, Iolanda Mazzucchelli, C. Cusa, Antonino Mazzone, Roberta Pacifici, Colomba Falcone
Publikováno v:
Journal of the American College of Cardiology. 38(7)
OBJECTIVES The aim of the study was to examine the inflammatory cytokines in patients with myocardial ischemia to evaluate whether silent ischemia patients exibit any particular cytokine pattern. BACKGROUND Silent myocardial ischemia is frequently ob
Autor:
Stefano Ghio, Gianna Tossini, Iolanda Mazzucchelli, Elena Ottini, Roberta Pacifici, Piergiorgio Zuccaro, C. Cusa, Antonino Mazzone, Monia Vezzoli
Publikováno v:
Clinical Chemistry and Laboratory Medicine. 39
Progression of atherosclerosis is currently believed to involve interactions between leukocytes and vascular endothelium. Epidemiological risk factors for atherosclerosis such as hypertension and smoking are known to cause endothelial dysfunction, wh
Autor:
A, Mazzone, C, Cusa, L, Bucci, M, Vezzoli, S, Ghio, I, Buggia, M B, Regazzi, G, Fossati, I, Mazzucchelli, D, Gritti
Publikováno v:
European journal of clinical investigation. 29(1)
Endothelial vascular tone modulators are thought to be involved in aetiopathogenesis of systemic sclerosis (SS) and of peripheral artery occlusive disease (PAOD). Iloprost, a prostacyclin (PGI2) analogue, induces clinical benefit in patients sufferin
Autor:
C. Canale, Iolanda Mazzucchelli, Antonino Mazzone, Gianluca Fossati, S. De Servi, D. Gritti, C. Cusa, Giovanni Ricevuti
Publikováno v:
Scopus-Elsevier
The aim of this study was to assess the expression of CD11b/CD18 integrin adhesion molecules on the phagocytes of patients with ischaemic diseases, and to evaluate the concentration of soluble adhesion molecules that are released from endothelium (sI